MRCC Q4 2025 Earnings EPS Surges Past Estimates with 1983 Beat STTK Q1 2026 Earnings Narrowerthanexpected loss highlights cost discipline amid prerevenue stage BHVN Q1 2026 Earnings EPS Miss Amid Continued RD Investment GRPN Q1 2026 Earnings Significant EPS Miss Amid Strategic Challenges Stock Rises on Hope Bicara Therapeutics BCAX Q1 2026 Earnings ClinicalStage Biotech Reports WiderthanExpected Loss Shares Rise CWK Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Resilience